Carlos A. Torres-Cabala, MD, Associate Professor of Pathology and Dermatology, Chief of Dermatopathology Section, The University of Texas MD Anderson Cancer Center, Houston, TXJonathan L. Curry, MD, Associate Professor of Pathology and Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

• Biology of Melanoma.- The Role of the Immune System and Immunoregulatory Mechanisms Relevant to Melanoma.- Epidemiology  and Clinical Characteristics of Melanoma.- Pathology of Melanoma.- Inherited Gene Mutations in Melanoma.- The MAPK Pathway in Melanoma.- The PI3K-AKT Pathway in Melanoma.- Biomarker Analysis for BRAF, NRAS, KIT, and BAP-1 Expression in Melanoma.- Molecular Platforms in Melanoma Mutation Analysis.- Immunotherapy in Melanoma.- Molecular Targeted Therapy in Melanoma.- Dermatologic Toxicities to Melanoma Targeted Therapy.

Carlos A. Torres-Cabala, MD, Associate Professor of Pathology and Dermatology, Chief of Dermatopathology Section, The University of Texas MD Anderson Cancer Center, Houston, TXJonathan L. Curry, MD, Associate Professor of Pathology and Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

• Biology of Melanoma.- The Role of the Immune System and Immunoregulatory Mechanisms Relevant to Melanoma.- Epidemiology  and Clinical Characteristics of Melanoma.- Pathology of Melanoma.- Inherited Gene Mutations in Melanoma.- The MAPK Pathway in Melanoma.- The PI3K-AKT Pathway in Melanoma.- Biomarker Analysis for BRAF, NRAS, KIT, and BAP-1 Expression in Melanoma.- Molecular Platforms in Melanoma Mutation Analysis.- Immunotherapy in Melanoma.- Molecular Targeted Therapy in Melanoma.- Dermatologic Toxicities to Melanoma Targeted Therapy.